|
Mr Burns is a U.S.-based biotechnology executive and director with a strong background in venture capital. Mr Burns is currently a Director of the Australian biotechnology company Progen Industries Limited, which specializes in the discovery and development of small molecule-based cancer therapeutics, a Director of firmView, a New York City-based software company, a Director of Euclid Systems Corp, an eye care company and StablEyes, Inc a biotechnology company in the eye care field and a Senior Advisor to Pharmalab, an Australian pharmaceutical manufacturing company. Mr Burns has previously been a Director of Synbiotics Corp, which specializes in animal health care. Prior to his twenty-five year career in venture capital, Mr Burns practiced law in New York with Milbank, Tweed, Hadley & McCloy. Mr Burns received his Bachelors degree from Dartmouth College and attained a LLB from Harvard Law School. | 